Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.31 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.31 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.31 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.31 |
| ▸ | MALT1 | Q9UDY8 | 1/20 | 0.31 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.30 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7547799 | 0.81 | NPC1 (0.37) | LMNACYP11B1CYP11B2 | |
| SCHEMBL10676056 | 0.79 | CNR1 (0.33) | TP53 | |
| SCHEMBL2514710 | 0.78 | ALOX15 (0.31) | CYP11B1CYP11B2 | |
| SCHEMBL2333074 | 0.78 | ALOX15 (0.31) | CYP11B1CYP11B2 | |
| SCHEMBL13993888 | 0.75 | PDK2 (0.40) | TP53 | |
| SCHEMBL14065330 | 0.74 | CALM1 (0.39) | LMNACYP11B1CYP11B2 | |
| SCHEMBL7483869 | 0.74 | CYP11B2 (0.34) | GRM5PIK3CDPIK3CAPIK3CBPIK3CG | |
| SCHEMBL9215304 | 0.74 | GABRA1 (0.35) | — | |
| SCHEMBL25698684 | 0.73 | LMNA (0.44) | GRM5LMNATP53 | |
| SCHEMBL30718118 | 0.72 | KMT2A (0.53) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010055042-A1 | 2-[(1-CYANOPROPYL)CARBAMOYL]-5-METHOXYMETHYL NICOTINIC ACIDS AND THE USE THEREOF IN MANUFACTURING HERBICIDAL IMIDAZOLINONES | BASF SE (DE) | 2010-05-20 | — | — | WO | claimed |
| EP-4001266-A2 | PROCESS FOR PREPARING METHOXY METHYL PYRIDINE DICARBOXYLATE | Adama Agan Ltd. (IL) | 2022-05-25 | — | — | EP | disclosed |
| EP-3782985-A1 | PROCESS FOR MANUFACTURING 5-METHOXYMETHYLPYRIDINE-2,3-DICARBOXYLIC ACID DERIVATIVES | BASF Agrochemical Products B.V. (NL) | 2021-02-24 | — | — | EP | disclosed |
| US-10858320-B2 | Process for manufacturing substituted 5-methoxymethylpyridine-2,3-dicarboxylic acid derivatives | BASF AGROCHEMICAL PRODUCTS B.V. (NL) | 2020-12-08 | — | — | US | disclosed |
| US-10669254-B2 | Process for preparing methoxy methyl pyridine dicarboxylate | ADAMA AGAN LTD. (IL) | 2020-06-02 | — | — | US | disclosed |
| US-20190276427-A1 | PROCESS FOR PREPARING METHOXY METHYL PYRIDINE DICARBOXYLATE | ADAMA AGAN LTD. (IL) | 2019-09-12 | — | — | US | disclosed |
| EP-2365965-B1 | PROCESS FOR MANUFACTURING SUBSTITUTED 3-PYRIDYLMETHYL AMMONIUM BROMIDES | BASF SE (DE) | 2019-01-09 | — | — | EP | disclosed |
| WO-2018091964-A1 | PROCESS FOR PREPARING METHOXY METHYL PYRIDINE DICARBOXYLATE | ADAMA AGAN LTD. (IL) | 2018-05-24 | — | — | WO | disclosed |
| EP-2982673-B1 | PROCESS FOR MANUFACTURING 5-CHLOROMETHYL-2,3-DICARBOXYLIC ANHYDRIDE | BASF SE (DE) | 2018-02-21 | — | — | EP | disclosed |
| US-20170226060-A1 | Process for Manufacturing Substituted 5-Methoxymethylpyridine-2,3-Dicarboxylic Acid Derivatives | BASF AGROCHEMICAL PRODUCTS B.V. (PR) | 2017-08-10 | — | — | US | disclosed |
| EP-2373623-B1 | PROCESS FOR MANUFACTURING SUBSTITUTED 5-METHOXYMETHYLPYRIDINE-2,3-DICARBOXYLIC ACID DERIVATIVES | BASF SE (DE) | 2017-03-29 | — | — | EP | disclosed |
| WO-2010055042-A1 | 2-[(1-CYANOPROPYL)CARBAMOYL]-5-METHOXYMETHYL NICOTINIC ACIDS AND THE USE THEREOF IN MANUFACTURING HERBICIDAL IMIDAZOLINONES | BASF SE (DE) | 2010-05-20 | — | — | WO | disclosed |
| WO-2010055042-A1 | 2-[(1-CYANOPROPYL)CARBAMOYL]-5-METHOXYMETHYL NICOTINIC ACIDS AND THE USE THEREOF IN MANUFACTURING HERBICIDAL IMIDAZOLINONES | BASF SE (DE) | 2010-05-20 | — | — | WO | disclosed |
| US-6441190-B1 | REACTING PYRIDINEDICARBOXYLIC ACID ANHYDRIDE OR PHTHALIC ANHYDRIDE COMPOUND WITH (R)2- AMINO-2,3-DIMETHYLBUTYRONITRILE IN PRESENCE OF WATER-FREE SOLVENT, HYDROLYSIS, TREATING WITH BASE; SEPARATION TO OBTAIN IMIDAZOLINONE COMPOUND | BASF AKTIENGESELLSCHAFT (DE) | 2002-08-27 | — | — | US | disclosed |
| US-20020077253-A1 | PROCESS FOR THE PREPARATION OF CHIRAL NICOTINIC, QUINOLINIC OR BENZOIC ACID IMIDAZOLINONE HERBICIDES | INTELLECTUAL PROPERTY DEPARTMENT (DE) | 2002-06-20 | — | — | US | disclosed |
| US-6339158-B1 | REACTING PYRIDINE OR QUINOLINE-2,3-DICARBOXYLIC ACID ANHYDRIDE DERIVATIVE WITH 2-AMINO-2,3-DIMETHYLBUTYRONITRILE IN PRESENCE OF NON-POLAR, WATER-FREE SOLVENT, TERTIARY AMINE, HYDROLYSIS, REACTING WITH BASE, SEPARATION, ACIDIFICATION | AMERICAN CYANAMID CO. | 2002-01-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170226060-A1 | Process for Manufacturing Substituted 5-Methoxymethylpyridine-2,3-Dicarboxylic Acid Derivatives | DDT, DDC, CYP4X1 | GRM5 392/4885LMNA 3233/4885TP53 3880/4885 |
| US-10669254-B2 | Process for preparing methoxy methyl pyridine dicarboxylate | MCCC2, C5, KDM4C | GRM5 1886/4885LMNA 1550/4885TP53 1905/4885 |
| US-20020077253-A1 | PROCESS FOR THE PREPARATION OF CHIRAL NICOTINIC, QUINOLINIC OR BENZOIC ACID IMIDAZOLINONE HERBICIDES | DDT, NQO2, NAPRT | GRM5 579/4885LMNA 2341/4885TP53 4097/4885 |
| US-10858320-B2 | Process for manufacturing substituted 5-methoxymethylpyridine-2,3-dicarboxylic acid derivatives | DDT, DDC, CYP4X1 | GRM5 392/4885LMNA 3233/4885TP53 3880/4885 |
| US-20190276427-A1 | PROCESS FOR PREPARING METHOXY METHYL PYRIDINE DICARBOXYLATE | MCCC2, C5, KDM4C | GRM5 1886/4885LMNA 1550/4885TP53 1905/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.